Innovative drug concept strengthens again, Shu Tai Shen rises more than 15% to hit a 3-year high.

In early trading, Shu Tai Shen surged over 15%, hitting a 3-year high. Keyin Technology, Borui Medicine, Jianyou Shares, Sanheng Guojian, Yifang Biology, and others were among the top gainers.